When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALRN - Aileron rallies on advancement of lead drug in early-stage study
Aileron Therapeutics Inc.
Nano cap Aileron Therapeutics (ALRN+28.2%) jumps on an 8x surge in volume in reaction to its announcement that it has completed enrollment in the dose optimization expansion cohort in its ongoing open-label Phase 1b clinical trial of lead candidate ALRN-6924, in development for the protection against multiple chemotherapy-induced bone marrow toxicities (severe anemia, thrombocytopenia, neutropenia).
More news on: Aileron Therapeutics, Inc., Healthcare stocks news, Stocks on the move,